These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 19141128)

  • 1. Methionine-enkephalin secreted by human colorectal cancer cells suppresses T lymphocytes.
    Ohmori H; Fujii K; Sasahira T; Luo Y; Isobe M; Tatsumoto N; Kuniyasu H
    Cancer Sci; 2009 Mar; 100(3):497-502. PubMed ID: 19141128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD10 enhances metastasis of colorectal cancer by abrogating the anti-tumoural effect of methionine-enkephalin in the liver.
    Kuniyasu H; Luo Y; Fujii K; Sasahira T; Moriwaka Y; Tatsumoto N; Sasaki T; Yamashita Y; Ohmori H
    Gut; 2010 Mar; 59(3):348-56. PubMed ID: 19828468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methionine enkephalin inhibits colorectal cancer by remodeling the immune status of the tumor microenvironment.
    Wang X; Li S; Yan S; Shan Y; Wang X; Jingbo Z; Wang Y; Shan F; Griffin N; Sun X
    Int Immunopharmacol; 2022 Oct; 111():109125. PubMed ID: 35988519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy of cancer via mediation of cytotoxic T lymphocytes by methionine enkephalin (MENK).
    Li W; Chen W; Herberman RB; Plotnikoff NP; Youkilis G; Griffin N; Wang E; Lu C; Shan F
    Cancer Lett; 2014 Mar; 344(2):212-22. PubMed ID: 24291668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methionine enkephalin (MENK) inhibits tumor growth through regulating CD4+Foxp3+ regulatory T cells (Tregs) in mice.
    Li X; Meng Y; Plotnikoff NP; Youkilis G; Griffin N; Wang E; Lu C; Shan F
    Cancer Biol Ther; 2015; 16(3):450-9. PubMed ID: 25701137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel mechanism of lung cancer inhibition by methionine enkephalin through remodeling the immune status of the tumor microenvironment.
    Zhang S; Huang H; Handley M; Griffin N; Bai X; Shan F
    Int Immunopharmacol; 2021 Oct; 99():107999. PubMed ID: 34315116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methionine enkephalin (MENK) suppresses lung cancer by regulating the Bcl-2/Bax/caspase-3 signaling pathway and enhancing natural killer cell-driven tumor immunity.
    Zhang S; Liu N; Ma M; Huang H; Handley M; Bai X; Shan F
    Int Immunopharmacol; 2021 Sep; 98():107837. PubMed ID: 34116288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-inflammatory and metabolic reprogramming effects of MENK produce antitumor response in CT26 tumor-bearing mice.
    Tuo Y; Zhang Z; Tian C; Hu Q; Xie R; Yang J; Zhou H; Lu L; Xiang M
    J Leukoc Biol; 2020 Jul; 108(1):215-228. PubMed ID: 31994797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methionine enkephalin, its role in immunoregulation and cancer therapy.
    Zhao D; Plotnikoff N; Griffin N; Song T; Shan F
    Int Immunopharmacol; 2016 Aug; 37():59-64. PubMed ID: 26927200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory role of methionine enkephalin in myeloid-derived suppressor cells and macrophages in human cutaneous squamous cell carcinoma.
    Bai X; Shan F; Qu N; Huang H; Handley M; Griffin N; Zhang S; Cao X
    Int Immunopharmacol; 2021 Oct; 99():107996. PubMed ID: 34311187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methionine enkephalin (MENK) inhibits human gastric cancer through regulating tumor associated macrophages (TAMs) and PI3K/AKT/mTOR signaling pathway inside cancer cells.
    Wang X; Jiao X; Meng Y; Chen H; Griffin N; Gao X; Shan F
    Int Immunopharmacol; 2018 Dec; 65():312-322. PubMed ID: 30343258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methionine enkephalin (MENK) mounts antitumor effect via regulating dendritic cells (DCs).
    Meng Y; Gao X; Chen W; Plotnikoff NP; Griffin N; Zhang G; Shan F
    Int Immunopharmacol; 2017 Mar; 44():61-71. PubMed ID: 28088065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The paradoxical role of methionine enkephalin in tumor responses.
    Tuo Y; Tian C; Lu L; Xiang M
    Eur J Pharmacol; 2020 Sep; 882():173253. PubMed ID: 32535097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methionine enkephalin (MENK) improves lymphocyte subpopulations in human peripheral blood of 50 cancer patients by inhibiting regulatory T cells (Tregs).
    Wang Q; Gao X; Yuan Z; Wang Z; Meng Y; Cao Y; Plotnikoff NP; Griffin N; Shan F
    Hum Vaccin Immunother; 2014; 10(7):1836-40. PubMed ID: 25424790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment of human peripheral blood lymphocytes with interleukin-2 or dexamethasone does not alter their response to Met-Enkephalin in a NK-cytotoxic assay.
    Martin-Kleiner I; Gabrilovac J
    Immunopharmacol Immunotoxicol; 1996 Feb; 18(1):37-57. PubMed ID: 8683038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NFAT-1 hyper-activation by methionine enkephalin (MENK) significantly induces cell apoptosis of rats C6 glioma in vivo and in vitro.
    Lu WC; Xie H; Tie XX; Wang R; Wu AH; Shan FP
    Int Immunopharmacol; 2018 Mar; 56():1-8. PubMed ID: 29324390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo killing effects of methionine enkephalin on osteosarcoma.
    Huang H; Wang X; Zhang S; Bai X; Griffin N; Shan Y; Shan F
    Int Immunopharmacol; 2023 Dec; 125(Pt B):111226. PubMed ID: 37976597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional modulation of the pathway between dendritic cells (DCs) and CD4+T cells by the neuropeptide: methionine enkephalin (MENK).
    Shan F; Xia Y; Wang N; Meng J; Lu C; Meng Y; Plotnikoff NP
    Peptides; 2011 May; 32(5):929-37. PubMed ID: 21335041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor Infiltrating T Lymphocytes and Apoptosis in Colorectal Cancer.
    Youssef MM; Paish EC; Murray JC; Farag NM; Saleh K; Ellis IO
    Egypt J Immunol; 2015; 22(1):19-28. PubMed ID: 26415369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Killing effect of methionine enkephalin on melanoma in vivo and in vitro.
    Wang DM; Jiao X; Plotnikoff NP; Griffin N; Qi RQ; Gao XH; Shan FP
    Oncol Rep; 2017 Oct; 38(4):2132-2140. PubMed ID: 28849104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.